Insider · CIK 0002042910
Amy Elazzouzi
Files at AURA (Aura Biosciences, Inc.). First filing Oct 29, 2024, latest Feb 17, 2026.
In brief
Amy Elazzouzi files SEC Form 4 as officer at AURA (Aura Biosciences, Inc.). Since Oct 29, 2024, Amy Elazzouzi has reported 0 open-market buys worth $0 and 8 open-market sells worth $138k, the latest filed on Feb 17, 2026.
A track record needs three past buys with six months of prices behind them; Amy Elazzouzi has 0, so none is measured yet.
The newest scored trade: sold $43k of AURA on Feb 17, 2026, filed Feb 17, 2026, scored 41 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $57k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AURA: Aura Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Aura Biosciences, Inc. | $43k 8,549 shares | -10% | +7% from low-31% from high | |
| 23Weak | Aura Biosciences, Inc. | $7,684 1,581 shares | -2% | +1% from low-39% from high | |
| 30Weak | Aura Biosciences, Inc. | $5,690 896 shares | -1% | +25% from low-45% from high | |
| 7Weak | AURAsell Aura Biosciences, Inc. | $52k 7,722 shares | -8% | +37% from low-43% from high | |
| 23Weak | Aura Biosciences, Inc. | $4,925 897 shares | -1% | +9% from low-54% from high | |
| 30Weak | Aura Biosciences, Inc. | $11k 1,404 shares | -2% | - | |
| 23Weak | Aura Biosciences, Inc. | $7,679 1,001 shares | -3% | - | |
| 30Weak | Aura Biosciences, Inc. | $5,938 553 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | AURA Aura Biosciences, Inc. | 8,549 0.01% of outstanding | $43k | Feb 17, 2026 | $7,684 |
| Jan 20, 2026 | AURA Aura Biosciences, Inc. | 1,581 0.00% of outstanding | $7,684 | Jan 20, 2026 | $5,690 |
| Oct 29, 2025 | AURA Aura Biosciences, Inc. | 896 0.00% of outstanding | $5,690 | Oct 29, 2025 | $52k |
| Aug 18, 2025 | AURA AURA BIOSCIENCES, INC. | 7,722 0.01% of outstanding | $52k | Aug 18, 2025 | none |
| Apr 16, 2025 | AURA Aura Biosciences, Inc. | 897 0.00% of outstanding | $4,925 | Apr 16, 2025 | $19k |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | 1,404 0.00% of outstanding | $11k | Feb 18, 2025 | $7,679 |
| Jan 21, 2025 | AURA Aura Biosciences, Inc. | 1,001 0.00% of outstanding | $7,679 | Jan 21, 2025 | $5,938 |
| Oct 29, 2024 | AURA Aura Biosciences, Inc. | 553 0.00% of outstanding | $5,938 | Oct 29, 2024 | none |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +23,540 | $0.00 | $0 | 143,600 | 42 d ago |
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +46,460 | $0.00 | $0 | 46,460 | 42 d ago |
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +44,528 | $0.00 | $0 | 120,060 | Mar 3, 2026 |
| Mar 2, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +80,472 | $0.00 | $0 | 80,472 | Mar 3, 2026 |
| Feb 17, 2026 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -8,549 | $5.06 | $43k | 75,532 | Feb 17, 2026 |
| Jan 20, 2026 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -1,581 | $4.86 | $7,684 | 84,081 | Jan 20, 2026 |
| Oct 29, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -896 | $6.35 | $5,690 | 85,662 | Oct 29, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +2,554 | $5.07 | $13k | 83,935 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +1,094 | $5.48 | $5,995 | 85,029 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +547 | $5.48 | $2,998 | 85,576 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +547 | $5.21 | $2,850 | 86,123 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +4,744 | $2.74 | $13k | 90,867 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +1,094 | $3.16 | $3,457 | 91,961 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock | +2,319 | $4.25 | $9,856 | 94,280 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -7,722 | $6.70 | $52k | 86,558 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -2,554 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -1,094 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -547 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -547 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -4,744 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -1,094 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Aug 18, 2025 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -2,319 | $0.00 | $0 | 0 | Aug 18, 2025 |
| Apr 16, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -897 | $5.49 | $4,925 | 81,381 | Apr 16, 2025 |
| Feb 18, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -1,404 | $7.75 | $11k | 82,278 | Feb 18, 2025 |
| Feb 3, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +45,240 | $0.00 | $0 | 83,682 | Feb 4, 2025 |
| Feb 3, 2025 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +29,760 | $0.00 | $0 | 29,760 | Feb 4, 2025 |
| Jan 21, 2025 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -1,001 | $7.67 | $7,679 | 38,442 | Jan 21, 2025 |
| Oct 29, 2024 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock | -553 | $10.74 | $5,938 | 39,443 | Oct 29, 2024 |
Questions about Amy Elazzouzi
Answered from the filings on this page, as of the latest one.
Is Amy Elazzouzi buying or selling?
In the last 12 months Amy Elazzouzi reported 0 open-market buys worth $0 and 3 open-market sells worth $57k on SEC Form 4; the latest was sold $43k of AURA on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Amy Elazzouzi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Amy Elazzouzi has 0.
Where does Amy Elazzouzi file Form 4?
Amy Elazzouzi has filed Form 4 at AURA (Aura Biosciences, Inc.) as Senior Vice President, Finance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.